East Hills, NY (March 7, 2006) - - Pall Corporation (NYSE: PLL) announced today that it was awarded a new long-term agreement with the English National Blood Service (NBS) to provide blood collection systems incorporating its proprietary filtration technology. Financial terms of the agreement were not disclosed.
"This is a major contract and incremental new business for our Leukotrap? family of filter systems. The NBS has always been on the leading edge in blood safety measures and we are pleased to be able to provide them with state-of-the-art technologies to help fulfill their core purpose to save and improve patients' lives," says Allan Ross, President of Pall Medical.
The NBS collects approximately 2 million units of blood each year. It is an integral part of the National Health Service and through its blood centers provides blood, blood components, products and tissues throughout England and North Wales.
Leukocyte reduction (also called leukoreduction or leukodepletion) - - the removal of contaminating white blood cells from blood products - - plays a pivotal role in improving patient outcomes and controlling health care costs. Pall is the leading global provider of filtration systems that reduce leukocytes from red cells, plasma and platelets providing customers with maximum flexibility in the manufacturing of life-saving blood products. As part of its mission to help safeguard the global blood supply, Pall also provides technologies that detect bacterial contamination of platelets, a leading infectious cause of morbidity from a transfusion, and reduce prions, the infectious agent believed to cause variant CJD, the human form of BSE, from red blood cells.
About Pall Corporation Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification, aerospace and broad industrial markets. Total revenues for fiscal 2005 were $1.9 billion. The Company headquarters are in East Hills, New York with extensive operations throughout the world. Visit Pall at www.pall.com.